Inhibiting the Keap1/Nrf2 Protein-Protein Interaction with Protein-Like Polymers

© 2024 The Authors. Advanced Materials published by Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 21 vom: 01. Mai, Seite e2311467
1. Verfasser: Carrow, Kendal P (VerfasserIn)
Weitere Verfasser: Hamilton, Haylee L, Hopps, Madeline P, Li, Yang, Qiao, Baofu, Payne, N Connor, Thompson, Matthew P, Zhang, Xiaoyu, Magassa, Assa, Fattah, Mara, Agarwal, Shivangi, Vincent, Michael P, Buyanova, Marina, Bertin, Paul A, Mazitschek, Ralph, Olvera de la Cruz, Monica, Johnson, Delinda A, Johnson, Jeffrey A, Gianneschi, Nathan C
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article antioxidant biomaterial drug delivery peptides polymers Kelch-Like ECH-Associated Protein 1 NF-E2-Related Factor 2 Polymers KEAP1 protein, human Peptides
LEADER 01000caa a22002652c 4500
001 NLM367321394
003 DE-627
005 20250305170007.0
007 cr uuu---uuuuu
008 240120s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202311467  |2 doi 
028 5 2 |a pubmed25n1223.xml 
035 |a (DE-627)NLM367321394 
035 |a (NLM)38241649 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Carrow, Kendal P  |e verfasserin  |4 aut 
245 1 0 |a Inhibiting the Keap1/Nrf2 Protein-Protein Interaction with Protein-Like Polymers 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 24.05.2024 
500 |a Date Revised 20.07.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2024 The Authors. Advanced Materials published by Wiley‐VCH GmbH. 
520 |a Successful and selective inhibition of the cytosolic protein-protein interaction (PPI) between nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associating protein 1 (Keap1) can enhance the antioxidant response, with the potential for a therapeutic effect in a range of settings including in neurodegenerative disease (ND). Small molecule inhibitors have been developed, yet many have off-target effects, or are otherwise limited by poor cellular permeability. Peptide-based strategies have also been attempted to enhance specificity, yet face challenges due to susceptibility to degradation and lack of cellular penetration. Herein, these barriers are overcome utilizing a polymer-based proteomimetics. The protein-like polymer (PLP) consists of a synthetic, lipophilic polymer backbone displaying water soluble Keap1-binding peptides on each monomer unit forming a brush polymer architecture. The PLPs are capable of engaging Keap1 and displacing the cellular protective transcription factor Nrf2, which then translocates to the nucleus, activating the antioxidant response element (ARE). PLPs exhibit increased Keap1 binding affinity by several orders of magnitude compared to free peptides, maintain serum stability, are cell-penetrant, and selectively activate the ARE pathway in cells, including in primary cortical neuronal cultures. Keap1/Nrf2-inhibitory PLPs have the potential to impact the treatment of disease states associated with dysregulation of oxidative stress, such as NDs 
650 4 |a Journal Article 
650 4 |a antioxidant 
650 4 |a biomaterial 
650 4 |a drug delivery 
650 4 |a peptides 
650 4 |a polymers 
650 7 |a Kelch-Like ECH-Associated Protein 1  |2 NLM 
650 7 |a NF-E2-Related Factor 2  |2 NLM 
650 7 |a Polymers  |2 NLM 
650 7 |a KEAP1 protein, human  |2 NLM 
650 7 |a Peptides  |2 NLM 
700 1 |a Hamilton, Haylee L  |e verfasserin  |4 aut 
700 1 |a Hopps, Madeline P  |e verfasserin  |4 aut 
700 1 |a Li, Yang  |e verfasserin  |4 aut 
700 1 |a Qiao, Baofu  |e verfasserin  |4 aut 
700 1 |a Payne, N Connor  |e verfasserin  |4 aut 
700 1 |a Thompson, Matthew P  |e verfasserin  |4 aut 
700 1 |a Zhang, Xiaoyu  |e verfasserin  |4 aut 
700 1 |a Magassa, Assa  |e verfasserin  |4 aut 
700 1 |a Fattah, Mara  |e verfasserin  |4 aut 
700 1 |a Agarwal, Shivangi  |e verfasserin  |4 aut 
700 1 |a Vincent, Michael P  |e verfasserin  |4 aut 
700 1 |a Buyanova, Marina  |e verfasserin  |4 aut 
700 1 |a Bertin, Paul A  |e verfasserin  |4 aut 
700 1 |a Mazitschek, Ralph  |e verfasserin  |4 aut 
700 1 |a Olvera de la Cruz, Monica  |e verfasserin  |4 aut 
700 1 |a Johnson, Delinda A  |e verfasserin  |4 aut 
700 1 |a Johnson, Jeffrey A  |e verfasserin  |4 aut 
700 1 |a Gianneschi, Nathan C  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 36(2024), 21 vom: 01. Mai, Seite e2311467  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnas 
773 1 8 |g volume:36  |g year:2024  |g number:21  |g day:01  |g month:05  |g pages:e2311467 
856 4 0 |u http://dx.doi.org/10.1002/adma.202311467  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 36  |j 2024  |e 21  |b 01  |c 05  |h e2311467